Arcadia Biosciences Overview
Company Headquarters: California, US
Founded: 2002
Workforce: ~40
Company Working: Arcadia Biosciences develops and markets high-value food ingredients, nutritional oils, and improved crops using biotechnology techniques. This consumer-driven agricultural technology company uses state-of-the-art gene-editing technology and advanced breeding techniques to naturally enhance the nutritional quality of grains and oilseeds to address the rapidly evolving trends in consumer health and nutrition. The company has also developed a broad pipeline of high-value crop productivity traits designed to enhance farm economics. It provides gamma-linolenic acid safflower (Carthamus tinctorius) oil under the brand SONOVA. It has collaboration with Dow AgroSciences LLC to develop and commercialize soybean traits. Based in Davis, it comprises administrative offices in Phoenix and Arizona in the US.
Some of the flagship brands of Arcadia Biosciences include GoodWheat, SONOVA, and HB4, among others. The company’s portfolio of agricultural traits (Nitrogen Use Efficiency, Salinity Tolerance, Water Use Efficiency) is being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. As of March 2019, the company’s patent portfolio included 153 issued patents and 63 pending patent applications worldwide in 30 patent families relating to the trait technologies.
This company, along with Bioceres Crop Solutions Corp. also constitutes a joint venture, Verdeca, which is focused on developing and deregulating crop varieties with next-generation agricultural technologies. Verdeca received commercialization approval from the US Food and Drug Administration (FDA) in 2017 for HB4 Drought Tolerance trait in soybean. Regulatory approvals for the same product were obtained in Argentina in 2015. Regulatory submissions were made in 2016 for import approval of HB4 soybeans into China, whereas regulatory approval for Brazil was submitted in 2018, and import approval in the European Union is to be submitted in 2019.
Strategy
Arcadia Biosciences aims to focus on acquisitions to enhance its product line. Additionally, it focuses on improving available products in the market. The company also emphasizes on increasing approvals from regulatory authorities for launching new products and reaching untapped markets. The primary aim of the company is to create value across the agricultural production and supply chain, beginning with enhanced crop productivity for farmers and ultimately to deliver accelerated innovation in nutritional quality consumer foods.
Also, with the establishment of Arcadia Specialty Genomics, it aims to develop novel hemp varieties possessing productivity, pest resistance and crop quality traits for license to cultivators, and derivative products serving the nutraceutical, life science, and food industries.
